A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0.524. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →BCM | Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine
Grant: None
Cancer Prevention and Research Institute of Texas
Grant: RP180672
Cancer Prevention and Research Institute of Texas
Grant: RP150578
Cancer Prevention and Research Institute of Texas
Grant: RP170719
Cancer Prevention and Research Institute of Texas
Grant: RP1806721
HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases
Grant: DK56338
HHS | NIH | National Cancer Institute
Grant: CA125123
HHS | NIH | National Heart, Lung, and Blood Institute
Grant: HG006348
HHS | NIH | National Center for Research Resources
Grant: RR024574
NCI NIH HHS
Grant: P30 CA125123
NHLBI NIH HHS
Grant: R01 HL132840
NIAID NIH HHS
Grant: R21 AI136876
NHGRI NIH HHS
Grant: UM1 HG006348
NCRR NIH HHS
Grant: S10 RR024574
NHGRI NIH HHS
Grant: U54 HG006348
NIDDK NIH HHS
Grant: P30 DK056338
FWCI
4.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals